According to the Complaint, Astrazeneca PLC is a multinational biopharmaceutical company and was one of the early front-runners in the race to develop a COVID-19 vaccine. In April 2020, the Company partnered with Oxford University to develop a potential recombinant adenovirus vaccine for the virus, later dubbed AZD1222.

According to the Complaint, Voyager Therapeutics, Inc. is a clinical-stage gene therapy company focused on the development of treatments for patients suffering from severe neurological diseases. Included in the Company’s preclinical programs is VY-HTT01 for Huntington’s Disease.

According to the Complaint, Anworth Mortgage Asset Corporation is a specialty finance mortgage company organized to qualify as a real estate investment trust (“REIT”).

According to the Complaint, Telenav, Inc. is a leading provider of connected car and location-based services.

According to the Complaint, Inphi Corporation is a fabless provider of high-speed analog and mixed signal semiconductor solutions for the communications and cloud markets.

According to the Complaint, 9F Inc. claims to be a leading digital financial account platform that integrates and personalizes financial services in China. It provides a comprehensive range of financial products and services across loan products, online wealth management products, and payment facilitation, all integrated under a single digital financial account.

According to the Complaint, Lizhi Inc. operates a social audio platform for user-generated content in China.

According to the Complaint, CleanSpark, Inc. provides advanced software and controls technology solutions, including end-to-end microgrid energy modeling, energy market communications, and energy management solutions.

According to the Complaint, Bit Digital, Inc. is a holding company that purports to engage in the bitcoin mining business through its wholly owned subsidiaries in U.S. and Hong Kong.

According to the Complaint, Walmart Inc. engages in the retail and wholesale operations in various formats worldwide. The Company operates in three segments: Walmart U.S., Walmart International, and Sam's Club. It operates supercenters, supermarkets, hypermarkets, warehouse clubs, cash and carry stores, discount stores, drugstores, and convenience stores; membership-only warehouse clubs; ecommerce websites, such as walmart.com, walmart.com.mx, asda.com, walmart.ca, flipkart.com, and samsclub.com; and mobile commerce applications. It operates approximately 11,500 stores and various e-commerce Websites under the 56 banners in 27 countries.

According to the Complaint, Decision Diagnostics Corp. purportedly offers, among other products and services, prescription and non-prescription diagnostics and home testing products. From March 2020 to at least June 2020, Defendants claimed that the Company had developed a finger-prick blood test that could detect COVID-19 in less than one minute. Defendants also made various representations regarding the Company’s progress towards achieving U.S. Food and Drug Administration emergency use authorization (“EUA”) for this purported COVID-19 finger-prick blood test.

According to the Complaint, Nielsen Holdings plc is a global measurement and data analytics company providing a view of consumers and markets worldwide.

According to the Complaint, Xilinx, Inc. (“Xilinx” or the “Company”) is a technology company that designs and develops programmable devices and associated technologies. In additional to its programmable platforms, Xilinx also provides design services, customer training, field engineering and technical support.

According to the Complaint, Penumbra, Inc. is a global healthcare company that develops, manufactures and sells innovative medical devices for patients suffering from stroke and other vascular and neurovascular diseases. Penumbra was the first company to market aspiration catheters, a specialized catheter designed to remove blood clots from arteries and veins in stroke patients, in a surgical procedure known as a thrombectomy.

According to the Complaint, Zagg Inc (“ZAGG” or the “Company”) designs, manufactures, and distributes mobile tech accessories for smartphones, tablets, smartwatches, and other mobile technology in the United States, Europe, and internationally.

According to the Complaint, GTT Communications, Inc. operates a global communications network, providing telecommunications services to large, multinational enterprises, carriers, and governments across five continents.

According to the Complaint, Sunesis Pharmaceuticals, Inc. is a biopharmaceutical company that develops and commercializes novel therapeutics in the areas of thrombosis and other hematologic disorders and inflammation in the United States.

According to the Complaint, Slack Technologies, Inc. (“Slack”) operates Slack, a business technology software platform that brings together people, applications, and data, and sells access to its Slack platform under a software-as-a-service model.

According to the Complaint, Tricida, Inc. is a pharmaceutical company that focuses on the development and commercialization of its drug candidate, veverimer (TRC101), a non-absorbed, orally administered polymer designed as a potential treatment for metabolic acidosis in patients with chronic kidney disease ("CKD"). Tricida has completed a Phase 3, double-blind, placebo-controlled trial of veverimer in patients with CKD and metabolic acidosis.

According to the Complaint, QuantumScape Corporation develops battery technology for electric vehicles and other applications. QuantumScape went public via business combination with Kensington Capital Acquisition Corp., which closed on November 25, 2020, with QuantumScape as the surviving public entity. Kensington was a special purpose acquisition company that was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination. Though Kensington was not limited to a particular industry or sector, it focused its search for a target business in the automotive and automotive-related sector.